Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiangqian Guo

Showing results (1-10 of 111) with videos related to

Pageof 12
Sort By:
Journal of Cachexia, Sarcopenia and Muscle|January 14, 2021
Comment on 'The expression landscape of cachexia-inducing factors in human cancers' by Freire et alLongxiang Xie, Xiangqian Guo
Molecular Therapy. Nucleic Acids|October 9, 2023
An important resource and analytic platform for human and mouse cardiovascular-related <i>cis</i>-regulatory elementsLongxiang Xie, Shengnan Wu, Xiangqian Guo
BMC Genomics|October 26, 2018
Distinct esophageal adenocarcinoma molecular subtype has subtype-specific gene expression and mutation patternsXiangqian Guo, Yitai Tang, Wan Zhu
Journal of Cellular Biochemistry|March 4, 2017
Regulatory Role of N<sup>6</sup> -methyladenosine (m<sup>6</sup> A) Methylation in RNA Processing and Human DiseasesWenqiang Wei, Xinying Ji, Xiangqian Guo, et al.
Cancers|March 11, 2020
The Application of Deep Learning in Cancer Prognosis PredictionWan Zhu, Longxiang Xie, Jianye Han, et al.
Journal of Hematology & Oncology|August 3, 2023
CD20 × CD3 bispecific antibodies for lymphoma therapy: latest updates from ASCO 2023 annual meetingXinyuan Liu, Juanjuan Zhao, Xiangqian Guo, et al.
Genomics Data|August 5, 2015
Molecular subtyping of leiomyosarcoma with 3' end RNA sequencingXiangqian Guo, Erna Forgó, Matt van de Rijn
Frontiers in Oncology|August 8, 2022
Editorial: Tumor-associated antigens and their autoantibodies, from discovering to clinical utilizationJianying Zhang, Xiangqian Guo, Bilian Jin, et al.
Frontiers in Genetics|October 27, 2022
Editorial: Bioinformatics tools (and web server) for cancer biomarker development, volume IILongxiang Xie, Liuyang Wang, Wan Zhu, et al.
The Lancet. Oncology|September 5, 2020
Risk factors for in-hospital mortality in patients with cancer and COVID-19Guosen Zhang, Yang An, Lu Zhang, et al.
Pageof 12

Showing results (1-10 of 111) with videos related to

Sort By:
Pageof 12
Journal of Cachexia, Sarcopenia and Muscle|January 14, 2021
Comment on 'The expression landscape of cachexia-inducing factors in human cancers' by Freire et alLongxiang Xie, Xiangqian Guo
Molecular Therapy. Nucleic Acids|October 9, 2023
An important resource and analytic platform for human and mouse cardiovascular-related <i>cis</i>-regulatory elementsLongxiang Xie, Shengnan Wu, Xiangqian Guo
BMC Genomics|October 26, 2018
Distinct esophageal adenocarcinoma molecular subtype has subtype-specific gene expression and mutation patternsXiangqian Guo, Yitai Tang, Wan Zhu
Journal of Cellular Biochemistry|March 4, 2017
Regulatory Role of N<sup>6</sup> -methyladenosine (m<sup>6</sup> A) Methylation in RNA Processing and Human DiseasesWenqiang Wei, Xinying Ji, Xiangqian Guo, et al.
Cancers|March 11, 2020
The Application of Deep Learning in Cancer Prognosis PredictionWan Zhu, Longxiang Xie, Jianye Han, et al.
Journal of Hematology & Oncology|August 3, 2023
CD20 × CD3 bispecific antibodies for lymphoma therapy: latest updates from ASCO 2023 annual meetingXinyuan Liu, Juanjuan Zhao, Xiangqian Guo, et al.
Genomics Data|August 5, 2015
Molecular subtyping of leiomyosarcoma with 3' end RNA sequencingXiangqian Guo, Erna Forgó, Matt van de Rijn
Frontiers in Oncology|August 8, 2022
Editorial: Tumor-associated antigens and their autoantibodies, from discovering to clinical utilizationJianying Zhang, Xiangqian Guo, Bilian Jin, et al.
Frontiers in Genetics|October 27, 2022
Editorial: Bioinformatics tools (and web server) for cancer biomarker development, volume IILongxiang Xie, Liuyang Wang, Wan Zhu, et al.
The Lancet. Oncology|September 5, 2020
Risk factors for in-hospital mortality in patients with cancer and COVID-19Guosen Zhang, Yang An, Lu Zhang, et al.
Pageof 12